Tsai Chen Lung sold CV

July 3, 2025 · Form 4 insider transaction

Tsai Chen Lung sold 90,534 shares of CapsoVision, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
90,534
Price
$0.00
Total value
N/A
RoleDirector
SecuritySeries H Preferred Stock
Transaction codeC: Conversion of a derivative
Transaction dateJuly 3, 2025
Filing dateJuly 7, 2025
Shares owned after0
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Each share of Series B preferred stock, Series D-1 preferred stock, Series E preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.; The securities are held by The Tsai Family Trust, for which the Reporting Person, together with his wife, are trustees.

View the original Form 4 on SEC EDGAR